Optic neuropathies for the neurologist

Seminars in Neurology

Volumn 20, Issue 1, 2000, Pages 97-110

  Purvin, Valerie A ^a,b  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^b MIDWEST EYE INSTITUTE   (United States)

Author keywords

Ischemic optic neuropathy; Optic disc edema; Optic neuritis; Optic neuropathy

Indexed keywords

AMIODARONE; DIGOXIN;

ARTICLE; CENTRAL SCOTOMA; CLINICAL EXAMINATION; DIAGNOSTIC APPROACH ROUTE; DISEASE COURSE; HUMAN; OPTIC DISK ANOMALY; OPTIC NERVE DISEASE; PRIORITY JOURNAL; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT;

HUMANS; OPTIC NERVE DISEASES;

EID: 0033924077     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (95)

1. Tan CT, Murray NMF, Sawyers D, Leonard TJK. Deliberate alteration of the visual evoked potential. J Neurol Neurosurg Psychiatry 1984;47:518-523
2. Hayreh SS, Zimmerman MB, Podhajsky P, Alward WLM. Nocturnal arterial hypotension and its role in optic nerve head and ocular disorders. Am J Ophthalmol 1994;117:603-624
3. Landau K, Winterkorn JMS, Mailloux LU, Vetter W, Napolitano. 24-hour blood pressure monitoring in patients with anterior ischemic optic neuropathy. Arch Ophthalmol 1996;114:570-575
4. Waybright EA, Selhorst JB, Combs J. Anterior ischemic optic neuropathy in internal carotid artery occlusion. Am J Ophthalmol 1982;93:42-47
5. Bogousslavsky J, Regli F, Zografos L, et al. Optico-cerebral syndrome: Simultaneous hemodynamic infarction of optic nerve and brain. Neurology 1987;37:263-268
6. Biousse V, Schaison M, Bousser M-G. Ischemic optic neuropathy in spontaneous extracranial dissections of the internal carotid artery. Neuro-ophthalmol 1996;16(suppl):272
7. Portnoy SL, Beer PM, Packer AJ, et al. Embolie anterior ischemic optic neuropathy. J Clin Neuro-ophthalmol 1989;9:21-25
8. Fry CI, Carter JE, Kanter MC, et al. Anterior ischemic optic neuropathy is not associated with carotid artery atherosclerosis. Stroke 1993;24:539-542
9. Muller M, Kessler C, Wessel K, et al. Low-tension glaucoma: A comparative study with retinal ischemic syndromes and ischemic optic neuropathy. Ophthalmic Surg 1993;24:835-838
10. Sergott RC, Cohen MS, Bosley TM, et al. Optic nerve decompression may improve the progressive form of nonarteritic ischemic optic neuropathy. Arch Ophthalmol 1989;107:1743-1754
11. Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA 1995;273:625-632
12. Johnson MW, Kincaid MC, Trobe JD. Bilateral retrobulbar optic nerve infarctions after blood loss and hypotension. Ophthalmology 1987;94:1577-1584
13. Katz DM, Trobe JD, Cornblath WT, et al. Ischemic optic neuropathy after lumbar spinal surgery. Arch Ophthalmol 1994;11: 925-931
14. Brown RH, Schauble JF, Miller NR. Anemia and hypotension as contributors to perioperative loss of vision. Anesthesiology 1994;80:222-226
15. Lee AG. Ischemic optic neuropathy following lumbar spine surgery: Case report. J Neurosurg 1995;83:348-349
16. Williams EL, Hart WVI Jr, Templehoff R. Postoperative ischemic optic neuropathy. Anesth Analag 1995;80:1018-1019.
17. Connolly SE, Gordon KB, Horton JC. Salvage of vision after hypotension-induced ischemic optic neuropathy. Am J Ophthalmol 1994;117:235-242
18. Hayreh SS. Anterior ischemic optic neuropathy: VIII. Clinical features and pathogenesis of post-hemorrhagic amaurosis. Ophthalmology 1987;94:1488-1502
19. Matzkin DC, Slamovits TL, Sachs R, Burde RM. Visual recovery in two patients after intravenous methylprednisolone treatment of central retinal artery occlusion secondary to Giant-cell Arteritis. Ophthalmology 1992;99:68-71
20. Lipton RB, Solomon S, Wertenbaker C. Gradual loss and recovery of vision in temporal arteritis. Arch Intern Med 1985;145: 2252-2253
21. Cornblath WT, Eggenberger ER. Progressive visual loss from giant cell arteritis despite high-dose intravenous methylprednisolone. Ophthalmology 1997;104:854-858
22. Chung SM, Gay CA, McCrary JA 3rd. Nonarteritic ischemic optic neuropathy. The impact of tobacco use. Ophthalmology 1994; 101:779-782
23. Talks SJ, Chong NH, Gibson JM, et al. Fibrinogen, cholesterol and smoking as risk factors for nonarteritic anterior ischemic optic neuropathy. Eye 1995;9:85-88
24. Regillo CD, Brown GC, Savino PJ, et al. Diabetic papillopathy: Patient characteristics and fundus findings. Arch Ophthalmol 1995;113:889-895
25. Pavan PR, Aiello LM, Wafai Z, et al. Optic disc edema in juvenile-onset diabetes. Arch Ophthalmol 1980;98:2193-2195
26. Barr CC, Glaser JS, Blankenship G. Acute disc swelling in juvenile diabetes. Arch Ophthalmol 1980;98:2185-2192
27. Beck RW, Clearly PA, Anderson MM, et al. A randomized, controlled trial of corticosteroid in the treatment of acute optic neuritis. N Engl J Med 1992;326:581-588
28. Schneck ME, Haegerstrom-Portnoy, G. Color vision defect type and spatial vision in the Optic Neuritis Treatment Trial. Invest Ophthalmol Vis Sci 1997;38:2278-2289
29. Cleary PA, Beck RW, Bourque LB, et al. Visual symptoms after optic neuritis; results from the Optic Neuritis Treatment Trial. J Neuro-ophthalmol 1997;17:1-28
30. Optic Neuritis Study Group. The clinical profile of optic neuritis: Experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 1991;109:1673-1678
31. Beck RW, Cleary PA, Backlund C. The course of visual recovery after optic neuritis: Experience of the Optic Neuritis Treatment Trial. Ophthalmology 1994;101:1771-1778
32. The Optic Neuritis Study Group. Visual function 5 years after optic neuritis: Experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 1997;115:1552-1554
33. Malessa R, Agelink MW, Diener H. Dysfunction of visual pathways in HIV-1 infection. J Neurol Sci 1995;130:82-87
34. Quiceno JI, Capparelli E, Sadun AA, et al. Visual dysfunction without retinitis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 1992;112:8-13
35. Sadun AA, Pepose JS, Madigan MC, Laycock KA, Tenhula WN, Freeman WR. AIDS-related optic neuropathy: A histological, virological and ultrastructural study. Graefes Arch Clin Exp Ophthalmol 1995;233:387-398
36. Berger JR, Sheremata WA, Resnick L, Atherton S, Fletcher MA, Norenberg M. Multiple sclerosis-like illness occurring with human immunodeficiency virus infection. Neurology 1989;39: 324-329
37. Berger JR, Tornatore C, Major EO, et al. Relapsing and remitting human immunodeficiency virus-associated leukoencephalopathy. Ann Neurol 1992;31:34-38
38. Gray F, Chimelli L, Mohr M, Clavelou P, Scaravelli F, Poirier J. Fulminating multiple sclerosis-like leukoencephalopathy revealing human immunodeficiency virus infection. Neurology 1991;41:105-109
39. Buton BJL, Leff AP, Plant GT. Steroid-responsive HIV optic neuropathy. J Neuro-ophthalmol 1998;18:25-29
40. Guy J, Mao J, Bidgood WD, Mancuso, Quisling RG. Enhancement and demyelination of the intraorbital optic nerve. Ophthalmology 1992;99:713-719
41. Jackson S, Sheppard S, Laitt RD, Kassner A, Moriarty D. Optic neuritis: MR imaging with combined fat- and-water-suppression techniques. Radiology 1998;206:57-63
42. Miller DH, Newton MR, Van der Poel JC, et al. Magnetic resonance imaging of the optic nerve in optic neuritis. Neurology 1988;38:175-179
43. Dunker S, Wiegand W. Prognostic value of magnetic resonance imaging in monosymptomatic optic neuritis. Ophthalmology 1996;103:1768-1773
44. Kapoor R, Miller DH, Jones SJ, Plant GT, et al. Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis. Neurology 1998;50: 230-237
45. The Optic Neuritis Study Group. Visual function 5 years after optic neuritis: Experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 1997;115:1552-1554
46. Optic Neuritis Study Group. The 5 year risk of MS after optic neuritis. Neurology 1997;49:1404-1413
47. Jacobs LD, Kaba SE, Miller CM, Priore RL, Brownscheidle CM. Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis. Ann Neurol 1997; 41:392-398
48. Soderstrom M, Ya-Ping J, Hillbert J, Link H. Optic neuritis: Prognosis for multiple sclerosis from MRI, CSF, and HLA findings. Neurology 1998;50:708-714
49. Lucchinetti CF, Kiers L, O'Duffy, Gomez MR, et al. Risk factors for developing multiple sclerosis after childhood optic neuritis. Neurology 1997;49:1413-1418
50. Purvin VA, Kawasaki A. Clinical features of perioptic neuritis: Poster presentation at North Am Neuro-ophthalmol Society meeting, Snow, MA, 1999
51. Fay AM, Kane SA, Kazim, Millar WS, Odel JG. Magnetic resonance imaging of optic perineuritis. J Neuro-ophthalmol 1997;17:247-249
52. Frohman L, Wolansky L. Magnetic resonance imaging of syphilitic optic neuritis/perineuritis. J Neuro-ophthalmol 1997; 17:57-59
53. Parmley VC, Schiffman JS, Maitland CG, et al. Does neuroretinitis rule out multiple sclerosis? Arch Neurol 1987;44:1045-1048
54. Golnik KC, Marotto ME, Fanoous MM, Heitter D, King LP, et al. Ophthalmic manifestations of rochalimaea species. Am J Ophthalmol 1994;118:145-151
55. Ormerod LD, Skolnick KA, Menosky MM, Pavan PR, Pon DM. Retinal and choroidal manifestations of cat-scratch disease. Ophthalmology 1998;105:1024-1031
56. Reed JB, Scales DK, Wong MT, Lattuada CP, Dolan MJ, Schwab IR. Bartonella henselae neuroretinitis in cat scratch disease. Ophthalmology 1998;105:459-466
57. Dreyer RF, Hopen G, Gass DM, et al. Leber's idiopathic stellate neuroretinitis. Arch Ophthalmol 1984;102:1140-1145
58. Maitland CG, Miller NR. Neuroretinitis. Arch Ophthalmol 1984; 102:1146-1150
59. Lyle TK, Wybar K. Retinal vasculitis. Br J Ophthalmol 1961; 45:778-788
60. Cogan DG. Retinal and papillary vasculitis. Paper read at The William Mackenzie Centenary Symposium on Ocular Circulation in Health and Disease, St Louis, 1969
61. Miller NR. The big blind spot syndrome: Unilateral disc edema without visual loss or increased intracranial pressure. In: Smith JL, ed. Neuro-ophthalmology Update. New York: Masson; 1977:163-169
62. Fong ACO, Schatz H, McDonald HR, Burton TC, et al. Central retinal vein occlusion in young adults (papillophlebitis). Retina 1991;11:3-11
63. Hoyt CS. Autosomal dominant optic atrophy: A spectrum of disability. Ophthalmology 1980;87:245-251
64. Kline LB, Glaser JS. Dominant optic atrophy: The clinical profile. Arch Ophthalmol 1979;97:1680-1686
65. Johnston RL, Seller MJ, Behnam JT. et al. Dominant optic atrophy: Refining the clinical diagnostic criteria in light of genetic linkage studies. Ophthalmology 1999;106:123-128
66. Newman NJ. Leber's Hereditary Optic Neuropathy: New genetic considerations. Arch Neurol 1993;50:540-548
67. Nikoskelainen, EK, Huoponen K, Juvonen V, et al. Ophthalmologic findings in Leber's hereditary optic neuropathy, with special reference to mtDNA mutations. Ophthalmology 1996; 103:504-514
68. Weiner NC, Newman NJ, Lessell S, Johns DR, Lott MT, Wallace DC. Atypical Leber's hereditary optic neuropathy with molecular confirmation. Arch Neurol 1993;50:470-473
69. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988;242:1427-1430
70. Johns DR, Smith KH, Miller NR. Leber's hereditary optic neuropathy: Clinical manifestations of the 3460 mutation. Arch Ophthalmol 1992;110:1577-1581
71. Johns DR, Smith KH, Savino PJ, Miller NR. Leber's hereditary optic neuropathy: Clinical manifestations of the 15257 mutation. Ophthalmology 1993;100:981-986
72. Harding AE, Sweeney MG, Miller DH, Mumford CJ, et al. Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain 1992;115:979-989
73. Flanigan KM, Johns DR. Association of the 11778 mitochondrial DNA mutation and demyelinating disease. Neurology 1993;43:2720-2722
74. Kellar-Wood H, Robertson N, Govan GG, Compston DAS, Harding AE. Leber's hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis. Ann Neurol 1994; 36:109-112
75. Riordan-Eva P, Sanders, Govan GG, Sweeney MG. et al. The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathologic mitochondrial DNA mutation. Am J Ophthalmol 1995;120:692
76. Carelli V, Ghelli A, Ratta M, Bacchilega E. et al. Leber's hereditary optic neuropathy: Biochemical effect of 11778/ND4 and 3460/ND1 mutations and correlation with the mitochondrial genotype. Neurology 1997;48:1623-1632
77. Carroll FD. Nutritional amblyopia. Arch Ophthalmol 1966; 76:406-411
78. Frisen L. Fundus changes in acute nutritional amblyopia. Arch Ophthalmol 1983;101:577-579
79. Rizzo JF. Adenosine triphosphate deficiency: A genre of optic neuropathy. Neurology 1995;45:11-16
80. Sadun AA, Marone JF, Muci-Mendoza R, Reyes L. et al. Epidemic optic neuropathy in Cuba. Arch Ophthalmol 1994;112:691-699
81. The Cuba Neuropathy Field Investigation Team. Epidemic optic neuropathy in Cuba: Clinical characterization and risk factors. N Engl J Med 1995;333:1176-1182
82. Newman NJ, Torroni A, Brown MD, Lott MT, Fernandez MM, et al. Epidemic neuropathy in Cuba not associated with mitochondrial DNA mutations found in Leber's Hereditary Optic Neuropathy patients. Am J Ophthalmol 1994;118:158-168
83. Rizzo JF, Lessell S. Tobacco Amblyopia. Am J Ophthalmol 1993;116:84-87
84. Cullom ME, Heher KL, Miller NR, Savino PJ, Johns DR. Leber's hereditary optic neuropathy masquerading as tobacco-alcohol amblyopia. Arch Ophthalmol 1993;111:1482-1485
85. Carmel R, Watkins D, Goodman SI, Rosenblatt DS. Hereditary defect of cobalamin metabolism presenting as a neurologic disorder in adulthood. N Engl J Med 1988;318:1738-1750
86. Miller NR. Toxic and deficiency optic neuropathies. In: Walsh and Hoyt's Clinical Neuro-ophthalmology. 5th ed. Baltimore: Williams and Wilkins; 1998:663-679
87. Mantyjarvi M, Tuppurainen K, Ikaheimo K. Ocular side effects of amiodarone. Surv Ophthalmol 1998;42:360-366
88. Gittiner JW, Asdouruan GK. Papillopathy caused by Amiodarone. Arch Ophthalmol 1987;106-5:349-351
89. Feiner LA, Younge BR, Kazmier FJ, Stricker BH, Fraunfelder FT. Optic neuropathy and Amiodarone therapy. Mayo Clin Proc 1987;62:702-717
90. Nazarian SM, Jay WM. Bilateral optic neuropathy associated with Amiodarone therapy. J Clin Neuro-ophthalmol 1988;8:25-28
91. Garrett SN, Kearney JJ, Schiffman JS. Amiodarone optic neuropathy. J Clin Neuro-ophthalmol 1988;8:105-110
92. Avery R, Jabs DA, Wingard JR, Vogelsang G, et al. Optic disc edema after bone marrow transplantation. Ophthalmology 1991;98:1294-1301
93. Piltz JR, et al. Digoxin toxicity. J Clin Neuro-ophthalmol 1993;13:275-280
94. Closson RG. Visual hallucinations as the earliest symptom of digoxin intoxication. Arch Neurol 1983;40:386
95. Horst HA, Kolenda KD, Duncker G, Schneck F, Lott H. Color vision deficiencies induced by subtoxic digoxin and digitoxin serum levels. Med Klin 1988;83:541-547